Header Logo

Connection

STEPHEN YENZEN LAI to Immunoblotting

Back to Details
This is a "connection" page, showing publications STEPHEN YENZEN LAI has written about Immunoblotting.
STEPHEN YENZEN LAI
Connection Strength
0.082
Immunoblotting
  1. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011 Apr 15; 17(8):2281-91.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.